Publications by authors named "Michael Yakes"

Claim this Profile
E
Enhanced Spin Coherence of a Self-Assembled Quantum Dot Molecule at the Optimal Electrical Bias.
Kha X Tran, Allan S Bracker, Michael K Yakes, Joel Q Grim, Samuel G Carter

Phys Rev Lett· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coherent Population Trapping Combined with Cycling Transitions for Quantum Dot Hole Spins Using Triplet Trion States.
Samuel G Carter, Stefan C Badescu, Allan S Bracker, Michael K Yakes, Kha X Tran

Phys Rev Lett· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Spin-Photon Interface Using Charge-Tunable Quantum Dots Strongly Coupled to a Cavity.
Zhouchen Luo, Shuo Sun, Aziz Karasahin, Allan S Bracker, Samuel G Carter, Michael K Yakes

Nano Lett· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scalable in operando strain tuning in nanophotonic waveguides enabling three-quantum-dot superradiance.
Joel Q Grim, Allan S Bracker, Maxim Zalalutdinov, Samuel G Carter, Alexander C Kozen, Michael Yakes

Nat Mater· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tunable Coupling of a Double Quantum Dot Spin System to a Mechanical Resonator.
Samuel G Carter, Allan S Bracker, Michael K Yakes, Maxim K Zalalutdinov, Mijin Kim

Nano Lett· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct excitation of a single quantum dot with cavity-SPDC photons.
Uttam Paudel, Jia Jun Wong, Michael Goggin, Paul G Kwiat, Allan S Bracker, Michael Yakes

Opt Express· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma.
Ronan Le Moigne, Blake T Aftab, Stevan Djakovic, Eugen Dhimolea, Eduardo Valle, F Michael Yakes

Mol Cancer Ther· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Atomic-Scale Clustering in III-V Semiconductor Alloys.
Louise C Hirst, Nicole A Kotulak, Stephanie Tomasulo, Josh Abell, María González, Michael K Yakes

ACS Nano· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083).
Han-Jie Zhou, Jinhai Wang, Bing Yao, Steve Wong, Stevan Djakovic, F Michael Yakes

J Med Chem· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis.
Daniel J Anderson, Ronan Le Moigne, Stevan Djakovic, Brajesh Kumar, Julie Rice, F Michael Yakes

Cancer Cell· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models.
Paul Foster, Kyoko Yamaguchi, Pin P Hsu, Fawn Qian, Xiangnan Du, F Michael Yakes

Mol Cancer Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway.
Peiwen Yu, A Douglas Laird, Xiangnan Du, Jianming Wu, Kwang-Ai Won, F Michael Yakes

Mol Cancer Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer.
Frauke Bentzien, Marcus Zuzow, Nathan Heald, Anna Gibson, Yongchang Shi, F Michael Yakes

Thyroid· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging crystal anisotropy for deterministic growth of InAs quantum dots with narrow optical linewidths.
Michael K Yakes, Lily Yang, Allan S Bracker, Timothy M Sweeney, Peter G Brereton

Nano Lett· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90.
Joerg Bussenius, Charles M Blazey, Naing Aay, Neel K Anand, Arlyn Arcalas, Michael Yakes

Bioorg Med Chem Lett· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors.
Moon H Kim, Amy Lew Tsuhako, Erick W Co, Dana T Aftab, Frauke Bentzien, F Michael Yakes

Bioorg Med Chem Lett· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors.
James W Leahy, Chris A Buhr, Henry W B Johnson, Byung Gyu Kim, Taegon Baik, Michael F Yakes

J Med Chem· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of an inhibitor of glucosylceramide synthase.
Steven Richards, Christopher J Larson, Elena S Koltun, Art Hanel, Vicky Chan, Michael Yakes

J Med Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth.
F Michael Yakes, Jason Chen, Jenny Tan, Kyoko Yamaguchi, Yongchang Shi

Mol Cancer Ther· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.
Jan M Williams, Jin Zhang, Paula North, Steven Lacy, Michael Yakes

Am J Physiol Renal Physiol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional control of self-assembled quantum dot configurations.
Michael K Yakes, Cory D Cress, Joseph G Tischler, Allan S Bracker

ACS Nano· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoscale tunable reduction of graphene oxide for graphene electronics.
Zhongqing Wei, Debin Wang, Suenne Kim, Soo-Young Kim, Yike Hu, Michael K Yakes

Science· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conductance anisotropy in epitaxial graphene sheets generated by substrate interactions.
Michael K Yakes, Daniel Gunlycke, Joseph L Tedesco, Paul M Campbell, Rachael L Myers-Ward

Nano Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Fawn Qian, Stefan Engst, Kyoko Yamaguchi, Peiwen Yu, Kwang-Ai Won, F Michael Yakes

Cancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647.
Steven B Gendreau, Richard Ventura, Paul Keast, A Douglas Laird, F Michael Yakes

Clin Cancer Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis